Medvax technologies, inc.

Medvax technologies, inc.

4.0 11 Reviews
Haven't used Medvax technologies, inc. yet?
Ask AI

Ask AI about Medvax technologies, inc.

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="medvax-technologies-inc" data-lang="en"></div>
More widgets

About Medvax technologies, inc.

MedVax's portfolio includes an autologous Adenovirus P53 dendritic cell vaccine in two FDA Phase II clinical trials, in Small Cell Lung Cancer, and Breast Cancer. MedVax also has a chimeric HER2 Peptide vaccine that is concluding a 2nd Phase I trial, and preparing for a Phase II trial.

Website
medvax.net
Address
200 southeast 1st street
Categories
Pharmaceuticals